Decoding PBM Reform Legislation: Essential Q1 2026 Insights for Self-Funded Plan Sponsors
With the conclusion of the first quarter of 2026, transparency and affordability continue to dominate the conversation around pharmacy benefits regulation....
RxBenefits's Posts
Carving Out Pharmacy Benefits: A Path to Savings and Control
As a self-funded employer, figuring out how best to manage your pharmacy benefits is one of your most important choices. Do...
From Transparency to Transformation: 5 Must-Know Regulatory Updates Shaping Pharmacy Benefits
The world of pharmacy benefits managers (PBMs) is undergoing a significant transformation. Driven by a nationwide push for greater transparency and...
Four Strategies for Managing GLP-1 Cost Trends
It seems impossible to discuss pharmacy benefits today without mentioning one class of drugs: GLP-1s. They are in news headlines,...
GLP-1s: The Billion-Dollar Buzz That Keeps Growing
It has only been a few short years since GLP-1 drugs exploded in popularity, yet their impact on the healthcare...
5 Questions to Test a Pharmacy Plan’s Transparency
Benefits advisors are expected to bring clarity to clients’ most complex and costly challenges, and pharmacy benefits often sit at...
What Transparency Really Means for Hospital Pharmacy Operations
From prior authorizations (PAs) and formulary restrictions to pharmacy steerage and increased costs for employees and patients, pharmacy leaders often...
Understanding GLP-1 Trends and Their Impact on Pharmacy Benefits Plans
Understanding GLP-1 Trends and Their Impact on Pharmacy Benefits Plans GLP-1s, originally approved for the treatment of Type 2 diabetes,...
PBM Reform: Changes on the horizon for employer drug plans: soothing balm or bitter pill?
PBM Reform: Changes on the horizon for employer drug plans: soothing balm or bitter pill? During its 2024 session, Congress...
